ArticleJournal of applied clinical medical physics2026
Machine learning-based integration of radiomics and dosiomics for early prediction of radiation-induced temporal lobe injury in nasopharyngeal carcinoma: A multicenter study.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning-based integration of radiomics and dosiomics for early prediction of radiation-induced temporal lobe injury in nasopharyngeal carcinoma: A multicenter study.Journal of applied clinical medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study developed and validated a multimodal machine learning model integrating clinical, radiomics, and dosiomics characteristics to predict radiation-induced temporal lobe injury (RTLI) in nasopharyngeal carcinoma patients.
methodsThis study utilized dual-center retrospective cohorts comprising 213 patients. From pre-treatment 3D computed tomography (CT) scans and radiation dose maps, we extracted 43 radiomics features and 43 dosiomics features. These quantitative imaging features underwent a rigorous three-stage selection pipeline-including auto-correlation analysis, significance testing (t-tests), and least absolute shrinkage and selection operator-regularized logistic regression (LASSO-LR)-yielding 24 optimal image-derived predictors (13 radiomics and 11 dosiomics features). In parallel, eight clinical features were preserved in all final models due to their established clinical relevance and prior biological significance. We systematically evaluated twelve predictive configurations by integrating three machine learning algorithms-Support Vector Machine (SVM), Random Forest (RF), and Logistic Regression (LR)-with four feature modalities: clinical-only, radiomics-only, dosiomics-only, and an integrated feature set.
resultsThe SVM-based integrated model demonstrated superior predictive performance, achieving an AUC of 0.819 during internal validation while maintaining robust generalizability in external testing (AUC = 0.714). The model exhibited excellent specificity (0.844) and remarkable cross-cohort stability, as evidenced by low performance variability (standard deviation: ±0.077 in validation, ±0.056 in testing). These findings highlight the synergistic value of integrating clinically established parameters with quantitative characterization of anatomical heterogeneity (radiomics) and radiation dose distribution patterns (dosiomics) for accurate prediction of radiation-induced temporal lobe injury.
conclusionThis clinically applicable predictive framework enables early identification of high-risk RTLI patients, facilitating timely interventions to mitigate neurotoxicity. The model's demonstrated multicenter validity, high specificity, and balanced performance across evaluation metrics address critical limitations of current prediction approaches, representing a significant advance in personalized radiation oncology for nasopharyngeal carcinoma patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.